Mihaly Ligmond InspectorProfile


This InspectorProfile is a report of relevant audit-related information on Mihaly Ligmond, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Biologics.

Product Description

This InspectorProfile report is updated through and lists Mihaly Ligmond's 180 inspections in 21 countries: Canada , United States , Germany , Ireland , United Kingdom , France , Italy , Denmark , Switzerland , Netherlands , Belgium , Sweden , Israel , India , Serbia , Ukraine , Mexico , Spain , Australia , Singapore , and Austria .

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Mihaly Ligmond's inspection information so that you can mitigate investigator-related risks.

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Mihaly Ligmond.

Example Report

Mihaly Ligmond FDA InspectorProfile Overview Example
Mihaly Ligmond FDA InspectorProfile Metrics Example
Mihaly Ligmond FDA InspectorProfile Citations Example
Mihaly Ligmond FDA InspectorProfile Inspections List
Add To Cart86 of Ligmond 483s in stock

Product details

  • Mihaly Ligmond's metrics:
    • 483 issue rate, total inspections, total 483s
    • Most common citations (based on CFR), CFR description, and citation frequency
    • Total inspections, total 483s
    • Longest / shortest inspection in duration - all time, last year
    • Total warning letters
  • Inspection details for each inspection (since 2000) Mihaly Ligmond has conducted including:

Note: The EIR and 483 documents are sold separately.

Add To Cart86 of Mihaly's 483s Available Now.